Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microtia - Congenital Ear Deformity Institute is a specialized pediatric surgical practice in San Antonio, Texas focused on the treatment of microtia, aural atresia, and related congenital ear deformities. The institute was founded by Dr. Arturo Bonilla and is best known for reconstructive surgery using autologous rib cartilage, hearing-related care coordination, and patient education for families managing congenital ear differences. It appears to operate as a clinical healthcare provider rather than a drug-development biotech or pharmaceutical company. The institute has also collaborated clinically with 3DBio Therapeutics in the first-in-human study of AuriNovo, a patient-specific 3D-bioprinted living tissue ear implant for microtia reconstruction. Its services are centered on surgical reconstruction, pediatric specialty care, and associated hearing management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microtia - Congenital Ear Deformity Institute.